Document Detail

Serum levels of neopterin, tumor necrosis factor-alpha and Interleukin-6 in preeclampsia: relationship with disease severity.
MedLine Citation:
PMID:  23161044     Owner:  NLM     Status:  In-Data-Review    
AIM: </strong> There are many studies evaluating the role of inflammation in the pathogenesis of preeclampsia. However, little is known about the relationship between the severity of inflammation and the severity of preeclampsia due to insufficient of studies reporting this matter. To investigate the maternal serum concentrations of IL-6, TNF-alpha and Neopterin in patients with mild preeclampsia and severe preeclampsia and HELLP (hemolysis, elevated liver enzymes, low platelet count) syndrome in preeclampsia and determine their association with the severity of the disease. <strong>
PATIENTS AND METHODS: </strong> Patients, hospitalized with the diagnosis of preeclampsia between October 2011 and March 2012, were included in the study. The patients with preeclampsia were divided into three groups as mild preeclampsia, severe preeclampsia and HELLP syndrome. The control group was comprised of normotensive and uncomplicated pregnant women. The serum levels of IL-6, TNF-alpha and Neopterin (NEO) were determined, using enzyme-linked immunosorbent assay. Spearman's rank correlation tests were used for the correlations between the serum levels of inflammatory markers and the severity of preeclampsia. <strong>
RESULTS: </strong> There was no observed significant difference among mean serum TNF-alpha and IL-6 levels of four groups (p > 0.05). The median serum concentration of NEO in subjects with mild preeclampsia of 14.1 nmol/L and severe preeclampsia of 14.8 nmol/L was significantly higher than that of 10.3 nmol/L in normotensive controls (p = 0.013; p = 0.000 respectively). In addition, the median serum concentration of NEO was detected to be highest in subjects with HELLP syndrome. The serum levels of NEO was well correlated with the severity of preeclampsia (r = 0.533, p = 0.000). <strong>
CONCLUSIONS: </strong> The serum levels of NEO, an important marker of cellular immunity, associated with severity of disease in patients with preeclampsia.
A Ozler; A Turgut; M E Sak; M S Evsen; H E Soydinc; O Evliyaoglu; T Gul
Related Documents :
23787544 - Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health ...
24063604 - Long-term reduction in poly(dimethylsiloxane) surface hydrophobicity via cold-plasma tr...
23976974 - Lactotransferrin in asian elephant (elephas maximus) seminal plasma correlates with sem...
25061704 - Evaluation of tranexamic acid and ϵ-aminocaproic acid concentrations required to inhib...
20887164 - Corifollitropin alfa: a novel long-acting recombinant follicle-stimulating hormone agon...
7440434 - Bovine prolactin, tsh, t and t concentrations as affected by tall fescue summer toxicos...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European review for medical and pharmacological sciences     Volume:  16     ISSN:  1128-3602     ISO Abbreviation:  Eur Rev Med Pharmacol Sci     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9717360     Medline TA:  Eur Rev Med Pharmacol Sci     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  1707-12     Citation Subset:  IM    
Department of Obstetrics and Gynecology, School of Medicine, Dicle University, Diyarbakir, Turkey.  
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Research on the molecular mechanism of Seretide treatment to asthma disease.
Next Document:  XPD and XRCC1 gene polymorphism in patients with normal and abnormalcervical cytology by pap smear.